Tiny study explores simple skin cleanse to stop staph spread to babies
NCT ID NCT06541145
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a 5-day skin treatment (mupirocin ointment in the nose and chlorhexidine baths) can reduce the amount of Staph aureus bacteria on mothers and their newborns. Only one mother participated, and researchers measured bacterial levels and surveyed her interest and compliance. The goal was to understand if such a treatment could limit bacteria spread between mother and baby.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mupirocin ointment and chlorhexidine cloths
- What this could lead to
- If successful, this could point toward a simple way to reduce Staph aureus transmission from mothers to newborns.
- What could go wrong
- This is a very small, completed study with only one participant, so results may not apply to others. It focuses on measurement, not treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL COLONIZATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University
Durham, North Carolina, 27703, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.